Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1120185.RAkb2pt4NZAl3e7rRzRjMApE7_avvsb1EacDyEs0qR7P4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1120185.RAkb2pt4NZAl3e7rRzRjMApE7_avvsb1EacDyEs0qR7P4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1120185.RAkb2pt4NZAl3e7rRzRjMApE7_avvsb1EacDyEs0qR7P4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1120185.RAkb2pt4NZAl3e7rRzRjMApE7_avvsb1EacDyEs0qR7P4130_provenance.
- NP1120185.RAkb2pt4NZAl3e7rRzRjMApE7_avvsb1EacDyEs0qR7P4130_assertion description "[In non-small-cell lung cancer (NSCLC), the identification of oncogenic driver mutations led to the definition of different clinical entities with different therapeutic opportunities, as demonstrated in patients harboring EGF receptor (EGFR) mutations or anaplastic lymphoma kinase translocations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1120185.RAkb2pt4NZAl3e7rRzRjMApE7_avvsb1EacDyEs0qR7P4130_provenance.
- NP1120185.RAkb2pt4NZAl3e7rRzRjMApE7_avvsb1EacDyEs0qR7P4130_assertion evidence source_evidence_literature NP1120185.RAkb2pt4NZAl3e7rRzRjMApE7_avvsb1EacDyEs0qR7P4130_provenance.
- NP1120185.RAkb2pt4NZAl3e7rRzRjMApE7_avvsb1EacDyEs0qR7P4130_assertion SIO_000772 24134423 NP1120185.RAkb2pt4NZAl3e7rRzRjMApE7_avvsb1EacDyEs0qR7P4130_provenance.
- NP1120185.RAkb2pt4NZAl3e7rRzRjMApE7_avvsb1EacDyEs0qR7P4130_assertion wasDerivedFrom befree-2016 NP1120185.RAkb2pt4NZAl3e7rRzRjMApE7_avvsb1EacDyEs0qR7P4130_provenance.
- NP1120185.RAkb2pt4NZAl3e7rRzRjMApE7_avvsb1EacDyEs0qR7P4130_assertion wasGeneratedBy ECO_0000203 NP1120185.RAkb2pt4NZAl3e7rRzRjMApE7_avvsb1EacDyEs0qR7P4130_provenance.
- befree-2016 importedOn "2016-02-19" NP1120185.RAkb2pt4NZAl3e7rRzRjMApE7_avvsb1EacDyEs0qR7P4130_provenance.